1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Elanco Animal Health Incorporated

Elanco Animal Health Incorporated

ELAN
Elanco Animal Health IncorporatedUS flagNew York Stock Exchange
25.84
USD
+0.36
- -
12.90BMarket Cap

Income Statement (USD)

APIChatGPT
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
2,909
2,914
2,889
3,067
3,071
3,271
4,764
4,411
4,417
4,439
4,715
+ Sales & Services Revenue
2,909
2,914
2,889
3,067
3,071
3,271
4,764
4,411
4,417
4,439
4,715
- Cost of Revenue
1,534
1,409
1,494
1,574
1,470
1,667
2,132
1,913
1,931
2,003
2,122
+ Cost of Goods & Services
1,534
1,409
1,494
1,574
1,470
1,667
2,132
1,913
1,931
2,003
2,122
Gross Profit
1,375
1,504
1,395
1,493
1,601
1,604
2,632
2,498
2,486
2,436
2,593
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
1,370
1,221
1,253
1,179
1,230
1,686
2,328
2,114
2,160
2,185
2,341
+ Selling, General & Admin
916
785
780
735
760
997
1,403
1,265
1,285
1,314
1,430
+ Research & Development
291
266
252
247
270
329
369
321
327
344
368
+ Other Operating Expense
163
171
221
197
200
360
556
528
548
527
543
Operating Income (Loss)
5
283
142
314
371
-82
304
384
326
251
252
- Non-Operating (Income) Loss
265
306
375
200
293
595
875
456
1,521
-237
476
+ Interest Expense, Net
- -
- -
- -
30
79
150
236
241
277
235
220
+ Interest Expense
- -
- -
- -
30
79
150
236
241
277
235
220
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
265
306
375
170
214
445
639
215
1,244
-472
256
Pretax Income
-260
-22
-233
114
78
-677
-571
-72
-1,195
488
-224
- Income Tax Expense (Benefit)
-49
26
78
28
10
-103
-88
6
36
150
8
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-211
-48
-311
86
68
-574
-483
-78
-1,231
338
-232
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-211
-48
-311
86
68
-574
-483
-78
-1,231
338
-232
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-211
-48
-311
86
68
-574
-483
-78
-1,231
338
-232
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-211
-48
-311
86
68
-574
-483
-78
-1,231
338
-232
EBIT
5
283
142
314
371
-82
304
384
326
251
252
EBITDA
242
538
461
610
685
435
1,020
1,066
1,020
913
932
EBITDA Margin (%)
8.33
18.45
15.95
19.88
22.31
13.3
21.41
24.17
23.09
20.57
19.77
EBITA
5
283
142
314
371
-82
304
384
326
251
252
Gross Margin (%)
47.28
51.64
48.29
48.68
52.13
49.04
55.25
56.63
56.28
54.88
54.99
Operating Margin (%)
0.19
9.72
4.93
10.23
12.08
-2.51
6.38
8.71
7.38
5.65
5.34
Profit Margin (%)
-7.25
-1.64
-10.75
2.82
2.21
-17.55
-10.14
-1.77
-27.87
7.61
-4.92
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
237
254
318
296
314
517
716
682
694
662
680
Basic Weighted Avg Shares
356
356
356
314
369
441
487
488
492
494
496
Basic EPS, GAAP
-0.59
-0.13
-0.87
0.28
0.18
-1.3
-0.99
-0.16
-2.5
0.68
-0.47
Basic EPS from Cont Ops
-0.59
-0.13
-0.87
0.28
0.18
-1.3
-0.99
-0.16
-2.5
0.68
-0.47
Diluted Weighted Avg Shares
356
356
356
314
370
441
487
488
492
497
496
Diluted EPS, GAAP
-0.59
-0.13
-0.87
0.28
0.18
-1.3
-0.99
-0.16
-2.5
0.68
-0.47
Diluted EPS from Cont Ops
-0.59
-0.13
-0.87
0.28
0.18
-1.3
-0.99
-0.16
-2.5
0.68
-0.47

Balance Sheet (USD)

APIChatGPT
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
- -
1,947
2,124
2,505
2,373
3,417
3,274
3,279
3,407
3,215
3,458
+ Cash, Cash Equivalents & STI
- -
259
323
475
334
495
638
345
352
468
545
+ Cash & Cash Equivalents
- -
259
323
475
334
495
638
345
352
468
545
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
631
602
709
890
1,077
1,028
1,002
1,010
886
940
+ Accounts Receivable, Net
- -
585
567
652
817
872
833
797
842
805
873
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
46
34
58
73
205
195
205
168
81
67
+ Inventories
- -
876
1,062
1,004
1,051
1,578
1,371
1,538
1,735
1,574
1,737
+ Raw Materials
- -
60
70
80
84
210
254
130
128
98
104
+ Work In Process
- -
453
580
570
603
625
565
683
814
783
837
+ Finished Goods
- -
410
452
401
403
772
598
783
857
754
871
+ Inventory Adjustments
- -
-46
-40
-47
-39
-29
-46
-58
-64
-61
-75
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
182
136
317
98
267
237
394
310
287
236
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
6,152
6,817
6,452
6,613
14,276
13,204
12,212
10,955
9,399
9,900
+ Property, Plant & Equip, Net
- -
742
920
922
955
1,316
1,055
999
1,026
993
1,409
+ Property, Plant & Equip
- -
1,503
1,754
1,801
1,886
2,354
2,096
1,722
1,841
1,851
2,361
- Accumulated Depreciation
- -
761
834
879
930
1,038
1,041
723
815
858
952
+ LT Investments & Receivables
- -
9
12
15
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
9
12
15
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
5,402
5,884
5,514
5,657
12,960
12,149
11,213
9,929
8,406
8,491
+ Total Intangible Assets
- -
5,198
5,642
5,463
5,472
12,612
11,759
10,835
9,588
8,095
8,187
+ Goodwill
- -
2,576
2,969
2,958
2,990
6,225
6,172
5,993
5,094
4,414
4,779
+ Other Intangible Assets
- -
2,621
2,673
2,505
2,483
6,387
5,587
4,842
4,494
3,681
3,408
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
204
242
51
185
348
390
378
341
311
304
Total Assets
- -
8,100
8,940
8,957
8,986
17,693
16,478
15,491
14,362
12,614
13,358
+ Payables & Accruals
- -
236
204
474
239
501
416
390
270
296
368
+ Accounts Payable
- -
228
204
205
223
501
416
390
270
296
368
+ Accrued Taxes
- -
8
5
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
-5
269
16
- -
- -
- -
- -
- -
- -
+ ST Debt
- -
- -
- -
29
24
555
294
388
38
44
74
+ ST Borrowings
- -
- -
- -
29
24
555
294
388
38
44
74
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
383
439
468
555
1,021
937
924
933
975
1,155
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
383
439
468
555
1,021
937
924
933
975
1,155
Total Current Liabilities
- -
619
643
971
818
2,077
1,647
1,702
1,241
1,315
1,597
+ LT Debt
- -
- -
- -
2,443
2,330
5,572
6,025
5,448
5,736
4,277
3,943
+ LT Borrowings
- -
- -
- -
2,443
2,330
5,572
6,025
5,448
5,736
4,277
3,943
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
453
517
345
290
1,568
1,298
1,052
1,162
926
1,271
+ Accrued Liabilities
- -
228
252
115
101
900
765
662
567
449
382
+ Pension Liabilities
- -
114
139
109
82
346
271
161
184
175
158
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
112
126
122
107
322
262
229
411
302
731
Total Noncurrent Liabilities
- -
453
517
2,788
2,620
7,140
7,323
6,500
6,898
5,203
5,214
Total Liabilities
- -
1,072
1,160
3,759
3,439
9,217
8,970
8,202
8,139
6,518
6,811
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
- -
5,403
5,636
8,650
8,696
8,738
8,777
8,817
8,870
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
- -
5,403
5,636
8,650
8,696
8,738
8,777
8,817
8,870
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
- -
- -
- -
16
84
-477
-979
-1,057
-2,288
-1,950
-2,182
+ Other Equity
- -
-457
-257
-222
-174
303
-209
-392
-266
-771
-141
Equity Before Minority Interest
- -
7,028
7,780
5,198
5,547
8,476
7,508
7,289
6,223
6,096
6,547
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
7,028
7,780
5,198
5,547
8,476
7,508
7,289
6,223
6,096
6,547
Total Liabilities & Equity
- -
8,100
8,940
8,957
8,986
17,693
16,478
15,491
14,362
12,614
13,358
Shares Outstanding
- -
356
366
366
373
472
473
474
493
494
497
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
- -
-259
-323
1,998
2,021
5,632
5,681
5,491
5,422
3,853
3,472
Net Debt to Equity
- -
-3.68
-4.16
38.43
36.43
66.45
75.67
75.33
87.13
63.21
53.03
Tangible Common Equity Ratio
- -
63.07
64.83
-7.59
2.12
-81.4
-90.08
-76.16
-70.49
-44.24
-31.72
Current Ratio
- -
3.15
3.3
2.58
2.9
1.65
1.99
1.93
2.75
2.44
2.17
Cash Conversion Cycle
- -
131.83
262.63
262.93
290.9
321.83
230.81
274.24
320.45
313.13
296.67

Cash Flow Statement (USD)

APIChatGPT
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-211
-48
-311
86
68
-574
-483
-78
-1,231
338
-232
+ Depreciation & Amortization
237
254
318
296
314
517
716
682
694
662
680
+ Non-Cash Items
-4
119
113
134
70
-153
338
310
1,108
-608
13
+ Stock-Based Compensation
13
20
25
26
49
47
66
59
46
55
68
+ Deferred Income Taxes
-76
-6
-13
-61
- -
-114
-148
-57
-80
-112
-134
+ Asset Impairment Charge
58
98
111
120
33
25
345
81
1,074
81
71
+ Other Non-Cash Adj
2
6
-10
48
-12
-111
75
227
68
-632
8
+ Chg in Non-Cash Work Cap
-16
-169
54
-29
-228
169
-88
-462
-300
149
99
+ (Inc) Dec in Accts Receiv
-95
-81
48
-122
-172
24
-35
14
-40
12
-12
+ (Inc) Dec in Inventories
15
-89
-39
-20
-34
-95
29
-269
-160
44
-57
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
116
37
-8
116
-29
362
-116
-98
-94
82
147
+ Inc (Dec) in Other
-52
-37
52
-3
7
-122
34
-109
-6
11
21
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
7
156
174
487
224
-41
483
452
271
541
560
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
20
7
38
9
- -
72
17
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
20
7
38
9
- -
72
17
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-100
-110
-117
-136
-197
-311
-197
-184
-154
-161
-276
+ Acq of Fixed Prod Assets
-100
-110
-99
-134
-140
-135
-159
-171
-140
-147
-276
+ Acq of Intangible Assets
- -
- -
-18
-2
-57
-176
-38
-13
-14
-14
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
1,660
- -
1,220
- -
- -
- -
- -
- -
+ Increase in Capital Stock
- -
- -
- -
1,660
- -
1,220
- -
- -
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
33
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
33
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
-5,283
-45
-882
- -
-33
-4,566
-342
13
-19
1,319
9
+ Cash from Divestitures
- -
- -
- -
- -
- -
435
- -
13
- -
1,360
9
+ Cash for Acq of Subs
-5,283
-45
-882
- -
-33
-5,001
-342
- -
-19
-41
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
368
-34
-3
- -
-5
-7
-8
-8
4
- -
-12
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-4,995
-182
-965
-127
-235
-4,779
-530
-179
-169
1,158
-279
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
2,492
-121
3,852
427
-752
-77
-1,475
-563
+ Cash From Debt
- -
- -
- -
2,500
- -
4,804
1,500
1,551
600
570
2,356
+ Repayments of Debt
- -
- -
- -
-8
-121
-952
-1,073
-2,303
-677
-2,045
-2,919
+ Other Financing Activities
5,353
-150
848
-4,187
-184
-118
-217
203
-6
-17
288
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
5,353
-150
848
-35
-305
4,954
210
-549
-83
-1,492
-275
Effect of Foreign Exchange Rates
-20
-26
8
29
-17
27
-31
-17
-12
-91
71
Net Changes in Cash
364
-176
57
325
-316
134
163
-276
19
207
6
EBITDA
242
538
461
610
685
435
1,020
1,066
1,020
913
932
EBITDA Margin (%)
8.33
18.45
15.95
19.88
22.31
13.3
21.41
24.17
23.09
20.57
19.77
Free Cash Flow
-94
46
57
351
27
-352
286
268
117
380
284
Net Cash Paid for Acquisitions
5,283
45
882
- -
33
4,566
342
-13
19
-1,319
-9
Free Cash Flow to Firm
- -
- -
- -
373
96
- -
- -
- -
- -
543
- -
Free Cash Flow to Equity
- -
53
113
2,855
-37
3,748
768
-471
54
-1,081
-279
Free Cash Flow per Basic Share
-0.26
0.13
0.16
1.12
0.07
-0.8
0.59
0.55
0.24
0.77
0.57
Price/Free Cash Flow
- -
- -
- -
15.86
25.9
50.14
20.33
9.38
17.26
8.58
13.44
Cash Flow to Net Income
-0.03
-3.25
-0.56
5.63
3.29
0.07
-1
-5.79
-0.22
1.6
-2.41
Capital Expenditures
-100
-110
-117
-136
-197
-311
-197
-184
-154
-161
-276